Hefei Lifeon Pharmaceutical Co., Ltd.
SZSE:003020 Rapport sur les actions
Capitalisation boursière : CN¥3.9b
Hefei Lifeon Pharmaceutical Bilan de santé
Santé financière contrôle des critères 6/6 Hefei Lifeon Pharmaceutical possède un total de capitaux propres de CN¥1.9B et une dette totale de CN¥59.6M, ce qui porte son ratio d'endettement à 3.1%. Son actif total et son passif total sont CN¥2.6B et de CN¥630.2M. L'EBIT de Hefei Lifeon Pharmaceutical est CN¥166.7M ce qui fait que son ratio de couverture des intérêts -18. Elle dispose de liquidités et de placements à court terme de CN¥487.6M.
Informations clés Ratio de couverture des intérêts -18x Argent liquide CN¥487.65m Fonds propres CN¥1.92b Total du passif CN¥630.16m Total des actifs CN¥2.55b
Mises à jour récentes de la santé financière
Afficher toutes les mises à jour
Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems Nov 05
Third quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.22 in 3Q 2023) Oct 30
Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet Sep 30
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 19% Sep 30
Second quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.34 in 2Q 2023) Aug 31
Hefei Lifeon Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50 May 23
Dividend of CN¥0.50 announced May 23
Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump May 22
Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues Apr 29
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Apr 24
Hefei Lifeon Pharmaceutical Co., Ltd., Annual General Meeting, May 14, 2024 Apr 23
Investor sentiment improves as stock rises 16% Apr 23
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Mar 30
Investor sentiment deteriorates as stock falls 18% Feb 02
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Dec 29
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Election of Shi Jing as an Independent Director Nov 18
Third quarter 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.46 in 3Q 2022) Nov 01
Investor sentiment improves as stock rises 18% Oct 30
New minor risk - Share price stability Oct 23
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.33 in 2Q 2022) Aug 29
Investor sentiment deteriorates as stock falls 16% Aug 03
Hefei Lifeon Pharmaceutical Co., Ltd. Declares Cash Dividend on A Shares for 2022, Payable on May 24, 2023 May 18
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 May 12
First quarter 2023 earnings released: EPS: CN¥0.54 (vs CN¥0.39 in 1Q 2022) Apr 18
Investor sentiment improves as stock rises 18% Feb 28
Third quarter 2022 earnings released: EPS: CN¥0.59 (vs CN¥0.35 in 3Q 2021) Oct 31
Investor sentiment improved over the past week Oct 18
Hefei Lifeon Pharmaceutical Co., Ltd. Announces Board Appointments Sep 01
Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.35 in 2Q 2021) Aug 29
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021R May 17
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021 May 12
First quarter 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.45 in 1Q 2021) Apr 29
No independent directors Apr 27
Hefei Lifeon Pharmaceutical Co. Proposes Final Cash Dividend for 2021 Apr 20
Full year 2021 earnings released: EPS: CN¥1.86 (vs CN¥1.94 in FY 2020) Apr 19
Third quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.49 in 3Q 2020) Oct 26
Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.53 in 2Q 2020) Aug 18
Investor sentiment deteriorated over the past week Jul 27
Investor sentiment improved over the past week Jun 02
Investor sentiment improved over the past week May 18
Hefei Lifeon Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2020 May 14
First quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.47 in 1Q 2020) Apr 28
Full year 2020 earnings released: EPS CN¥1.94 (vs CN¥1.51 in FY 2019) Apr 09
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Apr 09, 2021 Feb 24
Investor sentiment deteriorated over the past week Jan 13
Investor sentiment deteriorated over the past week Dec 25
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 003020 ( CN¥1.2B ) dépassent ses passifs à court terme ( CN¥537.8M ).
Passif à long terme: Les actifs à court terme de 003020 ( CN¥1.2B ) dépassent ses passifs à long terme ( CN¥92.4M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 003020 dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de 003020 a été réduit de 4.7% à 3.1% au cours des 5 dernières années.
Couverture de la dette: La dette de 003020 est bien couverte par le flux de trésorerie opérationnel ( 449.9% ).
Couverture des intérêts: 003020 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.
Découvrir des entreprises saines Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
